<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>APPLICATION FOR CERTIFICATION OF EXPORT PERFORMANCE OF UNITS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY SECTORS BY THE REGIONAL OFFICES OF THE DGFT AS PER CUSTOMS NOTIFICATION NO 21/2002 DATED 1.03.2002 AS AMENDED FROM TIME TO TIME</title>
    <link>https://www.taxtmi.com/acts?id=19422</link>
    <description>Application for DGFT certification requires applicant details, IEC, prior year physical exports and entitlement calculated at 25% of FOB exports, cumulative imports, proposed CIF imports and remaining entitlement; a signed undertaking that imports are for manufacture in the pharma/biotech sector, will not exceed the 25% entitlement, will be installed within six months, will not be transferred for seven years, and that the unit&#039;s R&amp;D wing is registered with the Department of Science and Industrial Research; CA verification and DGFT Regional Office certification enable duty free import under the relevant Customs Notification list, subject to conditions.</description>
    <language>en-us</language>
    <pubDate>Mon, 13 Apr 2015 18:30:56 +0530</pubDate>
    <lastBuildDate>Fri, 17 Apr 2015 16:39:58 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=381592" rel="self" type="application/rss+xml"/>
    <item>
      <title>APPLICATION FOR CERTIFICATION OF EXPORT PERFORMANCE OF UNITS IN THE PHARMACEUTICAL AND BIOTECHNOLOGY SECTORS BY THE REGIONAL OFFICES OF THE DGFT AS PER CUSTOMS NOTIFICATION NO 21/2002 DATED 1.03.2002 AS AMENDED FROM TIME TO TIME</title>
      <link>https://www.taxtmi.com/acts?id=19422</link>
      <description>Application for DGFT certification requires applicant details, IEC, prior year physical exports and entitlement calculated at 25% of FOB exports, cumulative imports, proposed CIF imports and remaining entitlement; a signed undertaking that imports are for manufacture in the pharma/biotech sector, will not exceed the 25% entitlement, will be installed within six months, will not be transferred for seven years, and that the unit&#039;s R&amp;D wing is registered with the Department of Science and Industrial Research; CA verification and DGFT Regional Office certification enable duty free import under the relevant Customs Notification list, subject to conditions.</description>
      <category>Act-Rules</category>
      <law>DGFT</law>
      <pubDate>Mon, 13 Apr 2015 18:30:56 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/acts?id=19422</guid>
    </item>
  </channel>
</rss>